AVITA Medical (AVHHL) Cash from Operations Growth (1y) (2020 - 2025)
Powered by 
Analysis
AVITA Medical (AVHHL) Cash from Operations Growth (1y) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 185.04 Bn | 179.44 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 124.95 Bn | 119.73 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 118.66 Bn | 109.84 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 104.58 Bn | 101.10 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 67.48 Bn | 66.94 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 33.95 Bn | 32.49 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.41 Bn | 30.47 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn | -12.60% |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 32.32% |
| Sep 30, 2025 | 27.65% |
| Jun 30, 2025 | 19.96% |
| Mar 31, 2025 | 50.59% |
| Dec 31, 2024 | 25.97% |
| Sep 30, 2024 | 19.61% |
| Jun 30, 2024 | -40.42% |
| Mar 31, 2024 | -129.96% |
| Dec 31, 2023 | -258.70% |
| Mar 31, 2023 | 3.17% |
| Mar 31, 2022 | -9.71% |
| Sep 30, 2021 | -70.22% |
| Jun 30, 2021 | -111.83% |
| Mar 31, 2021 | -17.08% |
| Dec 31, 2020 | -21.96% |
| Sep 30, 2020 | -58.02% |